Direct link to study, applies to both AstraZeneca and Johnson & Johnson - they think the issue can be addressed so adenovirus vaccines will not have this effect, but remains to be seen - speculatively maybe some other similar issue could pop up. Was not seen in trials because of very rare genetic combination resulting in vulnerability. https://www.nejm.org/doi/full/10.1056/NEJMoa2514824